BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 342293)

  • 1. Remissions of mycosis fungoides induced by nitrogen mustard (HN2). Topical treatment and hydration of tumours and plaques with HN2. Topical desensitization to HN2. A clinical and histopathological controlled study.
    Volden G; Larsen TE
    Dermatologica; 1978; 156(3):129-41. PubMed ID: 342293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Topical, intratumor and intravenous nitrogen mustard in the treatment of mycosis fungoides (author's transl)].
    Sánchez Yus E; Vanaclocha Sebastián F
    Med Clin (Barc); 1980 Sep; 75(5):199-202. PubMed ID: 6999251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycosis fungoides plaque stage treated with topical nitrogen mustard with and without attempts at tolerance induction: report from the Scandinavian mycosis fungoides study group.
    Molin L; Thomsen K; Volden G
    Acta Derm Venereol; 1979; 59(1):64-8. PubMed ID: 84470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of mycosis fungoides by topical application of nitrogen mustard].
    Waldorf DS
    Hautarzt; 1970 Jul; 21(7):319-20. PubMed ID: 5522289
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical nitrogen mustard induced carcinogenesis.
    Kravitz PH; McDonald CJ
    Acta Derm Venereol; 1978; 58(5):421-5. PubMed ID: 82352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete remissions of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2). Control of delayed hypersensitivity to HN2 by desensitization and by induction of specific immunologic tolerance.
    Van Scott EJ; Kalmanson JD
    Cancer; 1973 Jul; 32(1):18-30. PubMed ID: 4577503
    [No Abstract]   [Full Text] [Related]  

  • 7. Topical nitrogen mustard in mycosis fungoides.
    Zachariae H
    Int J Clin Pharmacol Res; 1985; 5(3):193-8. PubMed ID: 4018954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical nitrogen mustard in early mycosis fungoides. A 12-year experience.
    Zachariae H; Thestrup-Pedersen K; Søgaard H
    Acta Derm Venereol; 1985; 65(1):53-8. PubMed ID: 2578706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mycosis fungoides treated by local administration of a nitrogen mustard preparation, Erasol].
    Grunnet E; Thulin H; Zachariae H
    Ugeskr Laeger; 1975 Mar; 137(11):621-3. PubMed ID: 1145773
    [No Abstract]   [Full Text] [Related]  

  • 10. Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides.
    Chinn DM; Chow S; Kim YH; Hoppe RT
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):951-8. PubMed ID: 10192339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechlorethamine desensitization in therapy for mycosis fungoides. Topical desensitization to mechlorethamine (nitrogen mustard) contact hypersensitivity.
    Constantine VS; Fuks ZY; Farber EM
    Arch Dermatol; 1975 Apr; 111(4):484-8. PubMed ID: 1122150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Milia in regressing plaques of mycosis fungoides: provoked by topical nitrogen mustard or not?
    Kalayciyan A; Oguz O; Demirkesen C; Serdaroglu S; Kotogyan A
    Int J Dermatol; 2004 Dec; 43(12):953-6. PubMed ID: 15569030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycosis fungoides. Topical use of nitrogen mustard in recurrent cases.
    Arundell FD; Chan WH
    Calif Med; 1968 Dec; 109(6):458-61. PubMed ID: 5724878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal contact sensitivity to nitrogen mustard in lesions of cutaneous T-cell lymphoma (mycosis fungoides).
    Shelley WB
    Acta Derm Venereol; 1981; 61(2):161-4. PubMed ID: 6165197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Safe handling of nitrogen mustard. Risks for nurses in the treatment of mycosis fungoides].
    Cooijmans AC; Lensink JG; van Vloten WA
    TVZ; 1993 Feb; (4):143-7. PubMed ID: 8484873
    [No Abstract]   [Full Text] [Related]  

  • 16. Response of mycosis fungoides to topical chemotherapy with mechlorethamine.
    Ramsay DL; Parnes RE; Dubin N
    Arch Dermatol; 1984 Dec; 120(12):1585-90. PubMed ID: 6508330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photochemotherapy (PUVA) in the pretumour stage of mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Study Group.
    Molin L; Thomsen K; Volden G; Groth O
    Acta Derm Venereol; 1981; 61(1):47-51. PubMed ID: 6164214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Topical application of ACNU for the treatment of mycosis fungoides].
    Jimbow K; Horikoshi T; Kamimura M
    Gan To Kagaku Ryoho; 1982 Jul; 9(7):1231-6. PubMed ID: 6964047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical carmustine (BCNU) for patch/plaque mycosis fungoides.
    Zackheim HS
    Semin Dermatol; 1994 Sep; 13(3):202-6. PubMed ID: 7986689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epipodophyllotoxin (VP-16-213) in mycosis fungoides: A report from the Scandinavian mycosis fungoides study group.
    Molin L; Thomsen K; Volden G; Bergqvist-Karlsson A; Hallberg O; Hellbe L
    Acta Derm Venereol; 1979; 59(1):84-7. PubMed ID: 84480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.